Weiss Multi-Strategy Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-45,904	Closed	-$2.35M	–	64
2023 Q4	$2.35M	Buy	45,904 +28,335	+161%	+$1.49M	0.06%	352
2023 Q3	$1.02M	Buy	+17,569	New	+$1.08M	0.02%	433
2023 Q2	–	Sell	-29,484	Closed	-$2.04M	–	643
2023 Q1	$2.04M	Buy	+29,484	New	+$2.08M	0.05%	420
2022 Q2	–	Sell	-47,260	Closed	-$3.45M	–	662
2022 Q1	$3.45M	Sell	47,260 -219,428	-82%	-$14.7M	0.08%	311
2021 Q4	$16.6M	Buy	266,688 +161,376	+153%	+$9.47M	0.38%	66
2021 Q3	$6.23M	Buy	105,312 +1,850	+2%	+$122K	0.13%	215
2021 Q2	$6.91M	Buy	103,462 +1,371	+1%	+$89.4K	0.15%	206
2021 Q1	$6.45M	Sell	102,091 -28,157	-22%	-$1.75M	0.14%	213
2020 Q4	$8.08M	Sell	130,248 -52,029	-29%	-$3.2M	0.16%	179
2020 Q3	$11M	Buy	+182,277	New	+$11M	0.29%	110
2020 Q2	–	Sell	-231,906	Closed	-$13.9M	–	540
2020 Q1	$12.9M	Buy	231,906 +24,497	+12%	+$1.5M	0.5%	57
2019 Q4	$13.3M	Buy	+207,409	New	+$11.9M	0.22%	140
2019 Q3	–	Sell	-75,000	Closed	-$3.4M	–	591
2019 Q2	$3.4M	Buy	75,000 +10,000	+15%	+$466K	0.09%	219
2019 Q1	$3.1M	Buy	65,000 +20,000	+44%	+$996K	0.08%	274
2018 Q4	$2.34M	Sell	45,000 -5,171	-10%	-$278K	0.1%	215
2018 Q3	$3.12M	Buy	50,171 +3,340	+7%	+$198K	0.08%	275
2018 Q2	$2.59M	Buy	46,831 +16,831	+56%	+$909K	0.06%	309
2018 Q1	$1.9M	Hold	30,000	–	–	0.06%	333
2017 Q4	$1.84M	Sell	30,000 -40,000	-57%	-$2.5M	0.05%	360
2017 Q3	$4.46M	Sell	70,000 -8,905	-11%	-$520K	0.17%	177
2017 Q2	$4.4M	Buy	78,905 +3,720	+5%	+$202K	0.19%	165
2017 Q1	$4.09M	Buy	75,185 +42,522	+130%	+$2.33M	0.16%	169
2016 Q4	$1.91M	Buy	32,663 +7,507	+30%	+$410K	0.09%	210
2016 Q3	$1.36M	Buy	25,156 +3,114	+14%	+$200K	0.08%	263
2016 Q2	$1.62M	Sell	22,042 -9,168	-29%	-$648K	0.13%	215
2016 Q1	$1.99M	Buy	31,210 +486	+2%	+$30.6K	0.09%	266
2015 Q4	$2.11M	Sell	30,724 -21	-0.1%	-$1.39K	0.15%	167
2015 Q3	$1.82M	Buy	30,745 +694	+2%	+$44K	0.08%	199
2015 Q2	$2M	Sell	30,051 -110,949	-79%	-$7.31M	0.08%	243
2015 Q1	$9.1M	Buy	141,000 +86,000	+156%	+$5.38M	0.4%	68
2014 Q4	$3.25M	Sell	55,000 -55,000	-50%	-$3.1M	0.11%	167
2014 Q3	$5.63M	Sell	110,000 -7,650	-7%	-$382K	0.14%	170
2014 Q2	$5.71M	Sell	117,650 -2,030	-2%	-$100K	0.12%	195
2014 Q1	$6.22M	Sell	119,680 -35,800	-23%	-$1.9M	0.13%	201
2013 Q4	$8.26M	Buy	155,480 +4,630	+3%	+$236K	0.18%	163
2013 Q3	$6.98M	Buy	150,850 +50,850	+51%	+$2.23M	0.15%	178
2013 Q2	$4.47M	Buy	+100,000	New	+$4.34M	0.13%	224

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BMY Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 45,904 shares — an estimated $2.35M sold.

Weiss Multi-Strategy Advisers first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $16.6M in Q4 2021. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 45,904 Bristol-Myers Squibb shares in Q1 2024, an estimated $2.35M.
Weiss Multi-Strategy Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
Weiss Multi-Strategy Advisers's Bristol-Myers Squibb position peaked at $16.6M in Q4 2021.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.